Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Clinical Oncology and Cancer Research
Metadata
Title
Inhibition of the growth of Raji cells by precursor microRNA-5a
Authors
Dong-mei He
Qin Chen
Publication date
01-02-2010
Publisher
Tianjin Medical University Cancer Institute and Hospital
Published in
Clinical Oncology and Cancer Research / Issue 1/2010
Print ISSN: 1674-5361
Electronic ISSN: 1868-324X
DOI
https://doi.org/10.1007/s11805-010-0022-1

Other articles of this Issue 1/2010

Clinical Oncology and Cancer Research 1/2010 Go to the issue

OriginalPaper

Neoadjuvant combination chemotherapy with pegylated liposomal doxorubicin and vinorelbine for locally advanced breast cancer

OriginalPaper

Silencing Pin1 suppresses the expression and bioactivity of MMP-9 through NF-κB in colorectal carcinoma SW480 cells

OriginalPaper

Selective internal iliac artery oxaliplatin infusion: Another facultative treatment to unremitting hematuria in stage T4 bladder carcinoma

OriginalPaper

Genetic polymorphism in the second exon of HLA-DRB1 in cervical cancer

OriginalPaper

Alveolar rhabdomyosarcoma of the laryngohypopharynx: A case report

OriginalPaper

Wnt5a signaling — A new and attractive target for specific anticancer therapy
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits